Please select the option that best describes you:
Topics:
Radiation Oncology • Thoracic Malignancies
Do you preform elective nodal irradiation in patients with locally advanced NSCLC who are not candidates for or refuse chemotherapy?
Or do you use standared involved nodal fields, as is done with concurrent chemoRT?
Answer from: Radiation Oncologist at Academic Institution
No. Usually if they are not candidates for chemotherapy, there are reasons for it, such as medical comorbidities, that would make you want to limit your radiation fields as well. I would consider treating to a higher dose such as 66 Gy, without systemic therapy.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
Would not do ENI.
Data presented at ASTRO supports hypofractionation for these patients instead of 60-70 Gy in conventional fractionation without chemo
Comments
Radiation Oncologist at Mercy Radiation Oncology Clinic
As I was not at ASTRO, Can you please reference th...
As I was not at ASTRO, Can you please reference th...
Radiation Oncologist at Cancer Care Centers of Brevard
I wish, I can't seem to post links into mednet. G...
I wish, I can't seem to post links into mednet. G...
Radiation Oncologist at University of Wisconsin Hospital & Clinics
Here is the link to the abstract: https://www.ncbi...
Here is the link to the abstract: https://www.ncbi...
Answer from: Radiation Oncologist at Community Practice
When thinking through this, one can also consider how Bernie Fisher thought through the issue of "less treatment" (lumpectomy) for cancer and how Blake Cady thought about the futility of treating lymph nodes (spedometers whose removal do not disengage the engine). If the disease is already even regi...
Answer from: Radiation Oncologist at Academic Institution
There are mulitple publications from high volume centers showing that omission of ENI did not negatively impact outcomes.